Economic Impact of Aminoglycoside Toxicity and its Prevention Through Therapeutic Drug Monitoring

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.4, 1998-10, pp. : 385-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aminoglycoside Dosage Regimens After Therapeutic Drug Monitoring

By Kirkpatrick C.M.J.

Clinical Pharmacokinetics, Vol. 41, Iss. 10, 2002-01 ,pp. : 791-792

Adis International

Access to resources Recommend Favorite

Individualising Aminoglycoside Dosage Regimens after Therapeutic Drug Monitoring: Simple or Complex Pharmacokinetic Methods?

By Tod M.M.

Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. : 803-814

Adis International

Access to resources Recommend Favorite

Doctors’ perspectives towards a bedside aminoglycoside therapeutic drug monitoring service: a collaboration between pharmacy and clinical pharmacology

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 45, Iss. 2, 2015-06 ,pp. : 159-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic factors in aminoglycoside toxicity

By Fischel-Ghodsian Nathan

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 27-36

Future Medicine

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Clinical Research

By Neef Cees

Pharmaceutical Medicine, Vol. 22, Iss. 4, 2008-01 ,pp. : 235-244

Adis International

Access to resources Recommend Favorite